Literature DB >> 5543879

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

T S Zimmerman, O D Ratnoff, A E Powell.   

Abstract

Heterologous antiserum was prepared in rabbits against highly purified human antihemophilic factor (AHF, factor VIII). This antiserum blocked the clot-promoting properties of AHF and, when suitably absorbed, formed a single precipitin line against AHF upon immunoelectrophoresis. Material antigenically similar to normal AHF was detected in normal amounts in plasma concentrates in each of 22 patients with classic hemophilia, in a patient with an acquired circulating anticoagulant against AHF, and in a patient with deficiencies both of AHF and proaccelerin (factor V). AHF-like antigen was present in normal human serum. In contrast, material antigenically related to AHF was found in decreased amounts in the concentrates prepared from the plasma of 11 patients with von Willebrand's disease. The experiments described suggest that von Willebrand's disease is a disorder in which a true deficiency of AHF exists. Whether the AHF-like material found in classic hemophilia is nonfunctional through a defect in structure or through the intervention of an inhibitor has not been shown.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5543879      PMCID: PMC291913          DOI: 10.1172/JCI106480

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.

Authors:  E ADELSON; J J RHEINGOLD; O PARKER; M STEINER; J C KIRBY
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

2.  [ANTI-FACTOR VIII CIRCULATING ANTICOAGULANTS DURING HEMOPHILIA A. (NATURE AND MECHANISM OF ACTION)].

Authors:  M GOUDEMAND; M FOUCAUT; A HUTIN; A PARQUET-GERNEZ
Journal:  Nouv Rev Fr Hematol       Date:  1963 Nov-Dec

3.  The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG).

Authors:  R BIGGS; J M MATTHEWS
Journal:  Br J Haematol       Date:  1963-04       Impact factor: 6.998

4.  v. Willebrand's disease in Sweden; its pathogenesis and treatment.

Authors:  I M NILSSON; M BLOMBACK; B BLOMBACK
Journal:  Acta Med Scand       Date:  1959-06-30

5.  Immunization of rabbits against human anti-hemophilic factor (AHF).

Authors:  M D RICHARDS; T H SPAET
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

6.  Two types of haemophilia (A+ and A-): a study of 48 cases.

Authors:  K W Denson; R Biggs; M E Haddon; R Borrett; K Cobb
Journal:  Br J Haematol       Date:  1969-08       Impact factor: 6.998

7.  Studies of cross-reactivity of acquired factor VIII inhibitor activity in hemophilic plasma.

Authors:  C F Abildgaard; J Vanderheiden; A Lindley; F Rickles
Journal:  Thromb Diath Haemorrh       Date:  1967-12-31

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Observations on hemophilia, parahemophilia, and coexistent hemophilia and parahemophilia; alterations in the platelets and the thromboplastin generation test.

Authors:  R H SEIBERT; A MARGOLIUS; O D RATNOFF
Journal:  J Lab Clin Med       Date:  1958-09

10.  [Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers].

Authors:  J OERI; M MATTER; H ISENSCHMID; F HAUSER; F KOLLER
Journal:  Bibl Paediatr       Date:  1954
View more
  96 in total

1.  Problems in the detection of carriers of haemophilia A.

Authors:  D Meyer; A Plas; J P Allain; G M Sitar; M J Larrieu
Journal:  J Clin Pathol       Date:  1975-09       Impact factor: 3.411

2.  Von Willebrand's disease.

Authors: 
Journal:  Br Med J       Date:  1976-09-25

3.  Factor-VIII-related antigen: multiple molecular forms in human plasma.

Authors:  T S Zimmerman; J Roberts; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

4.  Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.

Authors:  S Lethagen; A S Harris; I M Nilsson
Journal:  Blut       Date:  1990-03

5.  Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology.

Authors:  T S Edgington
Journal:  West J Med       Date:  1975-05

6.  Studies on hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in the two sexes.

Authors:  G Filippi; P M Mannucci; R Coppola; A Farris; A Rinaldi; M Siniscalco
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

7.  Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

Review 9.  [Von Willebrand disease : diagnosis and management].

Authors:  C Antony; R Rossaint; G Schaelte
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

10.  Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.

Authors:  B Bennett; W B Forman; O D Ratnoff
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.